Search - tctmd.com

Displaying 581 - 600 of 600

Sort: Relevancy | Date

News Daily News

Las Sociedades Recomiendan los Requisitos para el Programa TAVR

L.A. McKeown

March 06, 2012

News Daily News

El Cierre del FOP Puede Prevenir Episodios Cerebrovasculares Recurrentes

Yael L. Maxwell

March 06, 2012

News Industry News

Boston Scientific Announces Launch of PROMUS Element™ Platinum Chromium Stent System in Japan

February 29, 2012

Presentation TCT 2012

The Mitochondrial Permeability Transition Pore is a Target for Pharmacological Cardioprotection in Human Hypertrophic Cardiomyopathy

Presenter: Paul S. Rees, Sean M. Davidson, Sian E. Harding, Perry M. Elliott, Derek J. Hausenloy, Derek M. Yellon

January 03, 2012

News Daily News

Hospital Readmission Post-PCI Linked to Increased Mortality

Yael L. Maxwell

December 05, 2011

News Industry News

Boston Scientific Receives FDA Approval for PROMUS Element™ Plus Platinum Chromium Stent System

November 21, 2011

News Industry News

Arterial Remodeling Technologies (“ART”) reports that its second-generation bioresorbable stent promotes vessel lumen enlargement in post-angioplasty in vivo model

November 02, 2011

News Daily News

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

September 12, 2011

News Industry News

JHP Pharmaceuticals to Produce Clinical Batches of Innovative Cardiac Drug

July 25, 2011

News Industry News

NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications

July 18, 2011

News Industry News

Vascular Solutions Introduces the OptiSeal™ Valved Peelable Introducer

January 26, 2011

News Industry News

Vascular Solutions introduces the SuperCross™ Microcatheter

January 23, 2011

Video

Beyond the Data: PCI Transitions Out of Surgical Centers

September 17, 2022

CME

Everyday Antiplatelet Decisions: Making the Right Choices

Video

» Interview

Dr. Chadi Alraies talks with Dr. Sheila Sahni about transitioning to practice in interventional cardiology

September 23, 2018

CME

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

CME

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

Partner Content

CME Landing Page

November 22, 2016

Partner Content

Registration: A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

November 21, 2016

BIO

Advertisement

Las Sociedades Recomiendan los Requisitos para el Programa TAVR

El Cierre del FOP Puede Prevenir Episodios Cerebrovasculares Recurrentes

Boston Scientific Announces Launch of PROMUS Element™ Platinum Chromium Stent System in Japan

The Mitochondrial Permeability Transition Pore is a Target for Pharmacological Cardioprotection in Human Hypertrophic Cardiomyopathy

Hospital Readmission Post-PCI Linked to Increased Mortality

Boston Scientific Receives FDA Approval for PROMUS Element™ Plus Platinum Chromium Stent System

Arterial Remodeling Technologies (“ART”) reports that its second-generation bioresorbable stent promotes vessel lumen enlargement in post-angioplasty in vivo model

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

JHP Pharmaceuticals to Produce Clinical Batches of Innovative Cardiac Drug

NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications

Vascular Solutions Introduces the OptiSeal™ Valved Peelable Introducer

Vascular Solutions introduces the SuperCross™ Microcatheter

Beyond the Data: PCI Transitions Out of Surgical Centers

Everyday Antiplatelet Decisions: Making the Right Choices

Dr. Chadi Alraies talks with Dr. Sheila Sahni about transitioning to practice in interventional cardiology

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

CME Landing Page

Registration: A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

Rahul Sharma, MD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content